Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of -1.31 is 78% above its 5-year average of -5.87, near the high end of its 5-year range (-21.70–-0.56).
10.08% below its 12-month average of -1.19.
Reported quarterly EPS; no daily interpolation. Q2 FY2026 (2026-06-30): -0.18.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 29 comparable quarters.
EARNINGS PER SHARE (EPS)
-1.31
EARNINGS PER SHARE (EPS) AVG TTM
-1.19
EARNINGS PER SHARE (EPS) AVG 3Y
-1.26
EARNINGS PER SHARE (EPS) AVG 5Y
-5.87
EARNINGS PER SHARE (EPS) AVG 10Y
-8.78
EARNINGS PER SHARE (EPS) AVG 15Y
N/A
EARNINGS PER SHARE (EPS) AVG 20Y
N/A
CURRENT VS TTM AVG
-10.08%
CURRENT VS 3Y AVG
-3.76%
CURRENT VS 5Y AVG
+77.70%
CURRENT VS 10Y AVG
+85.08%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Exicure, Inc.
Market Cap
$6.82M
Earnings Per Share (EPS)
-1.31
TTM Avg
-1.19
3Y Avg
-1.26
5Y Avg
-5.87
Market Cap
$6.87M
Earnings Per Share (EPS)
-16.00
TTM Avg
-9.75
3Y Avg
-5.91
5Y Avg
-4.74
Market Cap
$7.04M
Earnings Per Share (EPS)
-7.38
TTM Avg
-1.62
3Y Avg
-0.82
5Y Avg
-0.82
Market Cap
$6.88M
Earnings Per Share (EPS)
-26.72
TTM Avg
-36.23
3Y Avg
-30.51
5Y Avg
-16.78
Market Cap
$6.92M
Earnings Per Share (EPS)
-81.82
TTM Avg
-336.50
3Y Avg
-753.63
5Y Avg
-537.05
Market Cap
$6.65M
Earnings Per Share (EPS)
-16.46
TTM Avg
-132.36
3Y Avg
-129.45
5Y Avg
-404.68
Market Cap
$6.66M
Earnings Per Share (EPS)
-7.60
TTM Avg
-3746.91
3Y Avg
-66167.96
5Y Avg
-82548.30
Market Cap
$6.60M
Earnings Per Share (EPS)
-2.52
TTM Avg
-4.28
3Y Avg
-38.17
5Y Avg
-84.63
Market Cap
$6.54M
Earnings Per Share (EPS)
-1.26
TTM Avg
-1.73
3Y Avg
-1.08
5Y Avg
-0.87
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Exicure, Inc. (XCUR) | $6.82M | -1.31 | -1.19 | -1.26 | -5.87 |
| Bolt Biotherapeutics, Inc. (BOLT)vs › | $6.87M | -16.00 | -9.75 | -5.91 | -4.74 |
| Curanex Pharmaceuticals Inc Common Stock (CURX)vs › | $7.04M | -7.38 | -1.62 | -0.82 | -0.82 |
| Co-Diagnostics, Inc. (CODX)vs › | $6.88M | -26.72 | -36.23 | -30.51 | -16.78 |
| KALA BIO, Inc. (KALA)vs › | $6.92M | -81.82 | -336.50 | -753.63 | -537.05 |
| Enveric Biosciences, Inc. (ENVB)vs › | $6.65M | -16.46 | -132.36 | -129.45 | -404.68 |
| Aclarion, Inc. (ACON)vs › | $6.66M | -7.60 | -3746.91 | -66167.96 | -82548.30 |
| Ensysce Biosciences, Inc. (ENSC)vs › | $6.60M | -2.52 | -4.28 | -38.17 | -84.63 |
| Biomerica, Inc. (BMRA)vs › | $6.54M | -1.26 | -1.73 | -1.08 | -0.87 |
| NeuroSense Therapeutics Ltd. (NRSN)vs › | $7.14M | -8.91 | -9.90 | -14.45 | -12.10 |
Trailing EPS (TTM)
$-1.31
Forward EPS (Est.)
N/A
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | -0.79 |
| 2024-12-31 | -1.59 |
| 2023-12-31 | -2.11 |
| 2022-12-31 | -0.56 |
| 2021-12-31 | -21.70 |
| 2020-12-31 | -8.49 |
| 2019-12-31 | -13.68 |
| 2018-12-31 | -16.32 |
| 2017-12-31 | -8.37 |
| 2016-12-31 | -12.93 |
| 2015-12-31 | -10.04 |
